Millennium Management’s Pulse Biosciences PLSE Stock Holding History

Millennium Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$651K	Sell	23,488 -32,329	-58%	-$763K	﹤0.01%	4600
2026 Q1	$1.21M	Buy	+55,817	New	+$1.03M	﹤0.01%	4260
2025 Q2	–	Sell	-86,574	Closed	-$1.39M	–	6226
2025 Q1	$1.39M	Buy	+86,574	New	+$1.61M	﹤0.01%	4105
2024 Q4	–	Sell	-62,353	Closed	-$1.09M	–	6346
2024 Q3	$1.09M	Buy	62,353 +23,817	+62%	+$406K	﹤0.01%	4198
2024 Q2	$431K	Sell	38,536 -2,791	-7%	-$26.3K	﹤0.01%	4677
2024 Q1	$360K	Buy	+41,327	New	+$380K	﹤0.01%	5024
2023 Q4	–	Sell	-47,754	Closed	-$192K	–	6434
2023 Q3	$192K	Buy	47,754 +11,873	+33%	+$73.8K	﹤0.01%	5138
2023 Q2	$258K	Buy	35,881 +1,555	+5%	+$9.93K	﹤0.01%	4988
2023 Q1	$115K	Sell	34,326 -10,719	-24%	-$32.3K	﹤0.01%	5375
2022 Q4	$125K	Sell	45,045 -13,606	-23%	-$30.6K	﹤0.01%	5504
2022 Q3	$135K	Sell	58,651 -61,685	-51%	-$100K	﹤0.01%	5850
2022 Q2	$184K	Buy	+120,336	New	+$303K	﹤0.01%	5678
2021 Q3	–	Sell	-17,535	Closed	-$288K	–	7137
2021 Q2	$288K	Buy	+17,535	New	+$334K	﹤0.01%	5761
2020 Q4	–	Sell	-18,780	Closed	-$221K	–	5500
2020 Q3	$221K	Buy	18,780 +17	+0.1%	+$183	﹤0.01%	4022
2020 Q2	$196K	Buy	+18,763	New	+$169K	﹤0.01%	3851
2018 Q1	–	Sell	-12,272	Closed	-$290K	–	3986
2017 Q4	$290K	Buy	+12,272	New	+$290K	﹤0.01%	3371
2017 Q2	–	Sell	-11,975	Closed	-$244K	–	3766
2017 Q1	$244K	Buy	+11,975	New	+$163K	﹤0.01%	3131
2016 Q4	–	Sell	-30,674	Closed	-$193K	–	3637
2016 Q3	$193K	Buy	+30,674	New	+$156K	﹤0.01%	2994

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Millennium Management's PLSE Position: Q2 2026 in Review

Millennium Management reduced its Pulse Biosciences (PLSE) stake by 58% in Q2 2026, selling an estimated $763K and leaving 23,488 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #4600.

Millennium Management first reported a position in PLSE in Q3 2016 and has held it in 18 quarters since. The position peaked at $1.39M in Q1 2025. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Millennium Management held 23,488 shares of Pulse Biosciences worth $651K as of Q2 2026.
Millennium Management sold 32,329 Pulse Biosciences shares in Q2 2026, an estimated $763K.
Pulse Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4600 holding.
Millennium Management first reported a position in Pulse Biosciences in Q3 2016 and has held it in 18 quarters since.
Millennium Management's Pulse Biosciences position peaked at $1.39M in Q1 2025.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.